Composition and method to detect sensitivity to...

C - Chemistry – Metallurgy – 12 – P

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12P 21/08 (2006.01) A61K 39/00 (2006.01) C07K 14/705 (2006.01) C07K 16/30 (2006.01) C12N 5/28 (2006.01) G01N 33/574 (2006.01) G01N 33/577 (2006.01)

Patent

CA 2058420

2058420 9014595 PCTABS00002 This invention provides the hybridoma designated F 33 (ATCC No. HB 10155) and the monoclonal antibody produced by it. This invention also provides a method of detecting the sensitivity of a malignant cell or tissue to alpha interferon therapy which comprises contacting a sample of the malignant cell or tissue with a monoclonal antibody which recognizes an epitope of gp 160 cell surface antigen under conditions such that an antibody-antigen complex is formed between the monoclonal antibody and the gp 160 cell surface antigen, if the antigen is present in the sample; and detecting any complex so formed, the absence of complex indicating that the malignant cell or tissue is sensitive to alpha interferon therapy.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Composition and method to detect sensitivity to... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Composition and method to detect sensitivity to..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition and method to detect sensitivity to... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2090872

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.